USA flag logo/image

An Official Website of the United States Government

Pediatric Vision Scanner for the Eradication of Amblyopia

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
96149
Program Year/Program:
2010 / SBIR
Agency Tracking Number:
EY020699
Solicitation Year:
N/A
Solicitation Topic Code:
NEI
Solicitation Number:
N/A
Small Business Information
REBISCAN, LLC
30 Mount Auburn St. SUITE B Cambridge, MA 02138
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2010
Title: Pediatric Vision Scanner for the Eradication of Amblyopia
Agency: HHS
Contract: 1R43EY020699-01
Award Amount: $302,210.00
 

Abstract:

DESCRIPTION (provided by applicant): The Pediatric Vision Scanner (PVS) is a hand-held research prototype device that uses retinal birefringence scanning technology (co-invented by the PI) to diagnose the presence of amblyopia ( lazy eye ) and strabismus ( misaligned eyes). These medical eye conditions combine as the leading causes of preventable vision loss in children, and are thus major contributors to worldwide blindness. The overall aim of this project is to determine whether the PVS performance in the laboratory of the inventor can be duplicated in field use by independent investigators. A successful study will confirm that the PVS technology is sufficiently accurate in the field to allow early detection (and thus eradication) of amblyopia and strabismu s. Preliminary data indicate that this goal is attainable, but the design of the current prototype must be advanced to allow for definitive clinical testing to establish the PVS as a standard of care and create a path for insurance reimbursement and busine ss success. The current PVS device, which has a 98% accuracy rate detecting amblyopia or strabismus in initial clinical studies, was designed seven years ago for proof of concept. Capitalizing on the experience gained using the current prototype while usin g advances in electronics and optical technology, it is now possible to significantly improve the design to allow for large scale clinical testing, while also replacing development components that are now unnecessary for clinical testing. Phase I of the pr oject will be geared toward significantly improving the design of the PVS to make it suitable for clinical trials that will independently validate the device and thus create a path to market. A team of engineers will work in unison with a design firm to cr eate a new prototype on the conceptual level. Phase II of the SBIR award will support the assembly and initial debugging of this new design. This phase will also support the distribution of next-generation prototypes to three competitively-selected testing centers for independent assessments on its clinical accuracy, ongoing support of the devices during this phase, and collection of feedback to support design refinement for the final commercial product. PUBLIC HEALTH RELEVANCE: The United States Dep artment of Health and Human Services initiative, Healthy People 2010, places vision screening at a priority, with Objective 28-2 calling for an increase in the proportion of preschool children aged 5 years and under who receive vision screening. This proje ct will directly support that goal by supporting the design and commercialization the Pediatric Vision Screener, a high- technology device that is accurate enough to identify the vast majority of children with amblyopia and strabismus before they reach sch ool age.

Principal Investigator:

Justin Shaka

Business Contact:

Justin Shaka
jgshaka@rebiscan.com
Small Business Information at Submission:

REBISCAN, LLC
30 Mount Auburn St. SUITE B Cambridge, MA 02138

EIN/Tax ID: 180043168
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No